Victoza Liraglutide Compound peptide Pen - 6mg - 3ml

Weight Loss Support • Appetite Regulation • Metabolic Health

Victoza Liraglutide Compound Peptide Pen

Product Overview The Victoza Compound Peptide Pen offers a high-quality, compounded formulation of Liraglutide. Each prefilled pen delivers a total of 6mg of Liraglutide in a 3ml solution (concentration of 2mg/ml). Designed as a once-daily injectable medication, this pen is primarily used to improve blood sugar control in adults with Type 2 Diabetes, while also offering benefits for weight management as part of a comprehensive metabolic health plan.

Key Benefits

• Glycemic Control: Effectively lowers HbA1c and fasting glucose levels.
• Weight Management: aids in weight loss by reducing appetite and calorie intake.
• Cardiovascular Support: May reduce the risk of major cardiovascular events (such as heart attack or stroke) in adults with Type 2 Diabetes and heart disease.

Disclaimer

This product is intended strictly for laboratory research purposes only. It is not a medicine and has not been evaluated or approved by the South African Health Products Regulatory Authority (SAHPRA) for human or animal use.

Not for human consumption or medical use. Products sold on this website are not intended to diagnose, treat, cure, or prevent any disease. By purchasing, the customer confirms they are qualified to handle and use this product in accordance with applicable laws and regulations.